CAMP HILL, Pa. – Geisinger Holy Spirit will host two enrollment sessions this month for women who wish to participate in the DETECT cancer research study.
In the first study of its kind, conducted by Geisinger and Johns Hopkins University, 10,000 women will help determine if a blood test can be used as a cancer screening method in women without known cancer. This research study is open to female Geisinger patients, ages 65 to 75, with no prior history of cancer.
Enrollment sessions will be held Monday, Feb. 11, from 8 a.m. to 4 p.m. at Geisinger Holy Spirit Primary Care, 4230 Crums Mill Road, Harrisburg; and Wednesday, Feb. 27, from 8 a.m. to 4 p.m. at Geisinger Holy Spirit Primary Care, 335 Lambs Gap Road, Mechanicsburg. Participants must register at 570-387-2154.
For more information on the DETECT cancer research study, click here.
For media inquiries:
Ashley Andyshak Hayes
Marketing & Communications